Top Health Tech Companies in Delhi (101)
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.
Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.
Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.
Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.
Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.
RoundGlass is a global Wholistic #Wellbeing company dedicated to empowering and enabling people on their personal wellbeing journey. Our mission is simple, yet ambitious: inspire people to embrace a life of Wholistic Wellbeing to create a happier, healthier, and more joyful world. We work to achieve this by investing in and developing new technology, sharing knowledge, and focusing on action...
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, and deliver better care. Because informed decisions lead to better outcomes, Elsevier is a leader in information and analytics for customers across the global research and health ecosystems. Elsevier helps researchers and healthcare professionals advance science and improve...
Elsevier's Top Stability & Growth Strengths
Strong Market Position & Advantage: Elsevier is widely regarded as a dominant force in STM publishing with flagship journals (e.g., The Lancet, Cell) and critical platforms like ScienceDirect and Scopus. Feedback suggests this entrenched position supports stable demand and reinforces its central role in research and clinical workflows.
Profitability: The business delivers strong profits with high operating margins and contributes materially to its parent company’s earnings. Feedback suggests profitability has remained robust alongside increased article output and heavy platform usage.
Innovation-Driven Growth: The company is shifting toward higher-growth analytics and AI-enabled tools and expanding through targeted healthcare tech acquisitions. Feedback suggests rapid growth in open access output and new AI-assisted research tools positions the business well for future demand.
Mental Health remains a subject that is hugely discussed behind four walls, preventing people from coming out and talking about what may be ailing them. While Mental Health issues such as Anxiety and Depression have always existed, the recent pandemic has thrown it out there in the open. Adding to this is the hesitation to talk. Talk openly and willingly....
BMJ Group is a global healthcare knowledge provider. Our vision of a healthier world drives what we do; by sharing knowledge and expertise we help to improve patient outcomes through better evidence, better decisions and better systems. As an employer, and as a leading voice in global medicine and health, we strongly believe in anti-racism and equity because more equal societies...
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company materials and third‑party recognition portray a fully integrated CRO/CCO with leadership status, including widespread involvement in recent FDA/EMA novel therapies and recognition as a leading pharmacovigilance provider.
Strategic Partnerships: Recent collaborations with Microsoft and KX are positioned to enable AI‑driven efficiencies across clinical and commercial operations, with reported improvements in cycle times supporting operational scalability.
Investor Backing & Capital Strength: The 2025 take‑private by investment groups (including Elliott and Veritas) provides financial sponsorship to pursue tech‑enabled growth and operational repositioning.
Established in 1996, Centre for Sight has been continuously striving to provide specialized eye care for all. The group is a leading provider of specialized eye care with 50+ centres across 25+ cities in 12 states of India. A highly qualified clinical team leads Centre for Sight with modern infrastructure and world-class technology. But above all, the CFS group’s commitment...
Dentalkart, operated by Vasa Denticity Limited, is an Indian online marketplace and dental-products company serving dentists, healthcare professionals, students, and individuals. It offers more than 20,000 dental products, including equipment, instruments, materials, consumables, laboratory supplies, orthodontic and surgical products, books, and kits. Its mission is to make dental purchasing more accessible through broad selection, reliable delivery, and technology-enabled commerce across...
BluOne is a multinational ecosystem of conscious businesses operating across healthcare, publishing, research, design, education, technology, and marketing. Its services include end-to-end revenue cycle management for healthcare providers, literature publishing and promotion, research, design, marketing, technology, ecommerce, and talent-management solutions. The company says it began in 2016 to create conscious wealth supporting its nonprofit ventures, Auromir and Auroveda Foundation.
ResMed provides medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
ResMed's Top Stability & Growth Strengths
Strong Market Position & Advantage: Industry and company materials indicate ResMed is the leading player in global sleep‑apnea devices and masks, supported by scale and a large connected ecosystem (AirView/myAir). Philips’ U.S. consent decree and extended remediation have provided a multi‑year window that reinforced ResMed’s relative momentum.
Strong Revenue Growth: Recent quarters show continued year‑over‑year revenue growth with margin expansion, driven by device demand and recurring masks/accessories. Management commentary and investor materials point to sustained momentum through FY2026 to date.
Diversified Revenue Streams: A large installed base of connected devices underpins recurring resupply revenue and remote monitoring workflows. Ownership of Brightree and MatrixCare adds out‑of‑hospital software that complements the core hardware franchise.
Digilooks Healthcare, An Initiative by Digiarway Healthcare Private Limited is a STARTUP registered under STARTUP INDIA and ISO 9001:2015 & ISO 27001:2011 Company, Funded by a bunch of Angel Investors. It offers a Digital Healthcare Solution for Educational Institutions. We help schools to comply with the mandatory guidelines issued by The Ministry of Education (MoE), formerly the Ministry of Human...
Redcliffe Labs is India’s fastest-growing omnichannel Pan India diagnostic network, revolutionizing the diagnostic domain with its comprehensive portfolio approach. Its wide network of labs and collection centres across India follows stringent internal and external quality protocols to deliver accurate results to patients for preventive checkups and disease management. All Labs adhere to NABL guidelines. From routine pathology tests to specialized...
As India's leading integrated healthcare company, Practo has been on a mission to make quality healthcare accessible and affordable to all by connecting the entire healthcare ecosystem including patients, doctors, clinics, hospitals, pharmacies, and diagnostics in a seamless and cohesive manner. Practo effortlessly streamlines the patient's healthcare journey right from primary healthcare, viz. finding and booking an appointment with verified...
Brainpan Innovations provides state-of-the-art solutions for Electronic Health Records (EHR), Hospital Information System (HIS), Voice Assistant, Disease Atlas, Real World Evidence (RWE), and Clinical Trials.
A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how...
GSK's Top Stability & Growth Strengths
Strong Market Position & Advantage: GSK is positioned as a top-tier global biopharmaceutical company by revenue while showing category leadership in vaccines and HIV, anchored by franchises such as Shingrix and ViiV’s portfolio. Its consistent top-10/12 standing and segment leadership in vaccines, respiratory, and HIV support a stable competitive footing.
Resilient & Sustainable Growth: Revenue and earnings momentum are supported by broad-based growth across Specialty Medicines and continued contributions from Vaccines, alongside reaffirmed multi-year sales ambitions. Guidance for continued turnover and profit expansion indicates an expectation of ongoing, steadier growth rather than a one-off spike.
Healthy Cash Flow: Operating cash generation is described as strong and is being used to fund R&D investment and shareholder returns such as dividends and buybacks. This cash profile supports resilience through investment cycles and potential volatility in specific product areas.
LGC is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. Its high quality product portfolio is comprised of mission-critical tools for genomic analysis and for quality assurance applications, which are typically embedded and recurring within our customers’ products and workflows and are valued for...
LGC's Top Stability & Growth Strengths
Strong Market Position & Advantage: Holding the UK’s National Measurement Laboratory designation and Government Chemist role, plus leading positions in reference materials, proficiency testing, and agrigenomics/genotyping, reinforces defensible niche leadership. Acquisitions and widespread adoption of technologies like KASP genotyping underscore recognized authority in core segments.
Strong Revenue Growth: Reported revenue increased year over year in FY25, reversing the prior year’s dip. Adjusted EBITDA also rose, indicating improved top-line momentum alongside better operating results.
Future-Ready Strategy: Large-scale site expansions (Toronto, Guildford, Berlin) and integration of recent acquisitions point to capacity build-out and a scale-focused operating model. A new CEO, business-unit consolidation, and an Innovation Hub signal intent to sustain growth through portfolio development and execution.
PATH is a global nonprofit dedicated to health equity. With more than 40 years of experience forging multisector partnerships, and with expertise in science, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales up innovative solutions to the world’s most pressing health challenges. *PATH has become aware of scams involving false job offers.* Please advise: - PATH will never...
Nirogstreet as a concept is working to make #Ayurveda first call of treatment. We are organising supply chain of Ayurveda services and medicine to deliver the care that people trust.
India IVF Fertility is India's leading chain of multi-speciality fertility centre and is best-in-class in the field of infertility treatments. We make the smile on faces of childless couples. Our mission is to provide quality services by being honest, affordable and reasonable. We have the world class State of the art infrastructure with all the modern amenities available under one roof. We...
